HIGHLIGHTS
- who: Martin Helán from the (CSIC), Spain University of Salamanca, Spain have published the research: Prognostic value of soluble endoglin in patients with septic shock and severe COVID-19, in the Journal: (JOURNAL)
- what: In this trial, the authors sought to test the prognostic potential (in prediction of early (D3), D28 and/or D90 mortality) of sEng in a larger and more precisely defined cohort of patients suffering from septic shock and the cohort of patients with a severe COVID-19 and compare the result between these two diagnoses. Although the primary objective was . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.